Colorectal cancer test use among hispanic and non-hispanic U.S. populations

Preventing Chronic Disease

Volumn 3, Issue 2, 2006, Pages 1-12

  Pollack, Lori A ^a   Blackman, Donald K ^a   Wilson, Katherine M ^a   Seeff, Laura C ^a   Nadel, Marion R ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978759406     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. American Cancer Society. Cancer facts and figures, 2005. Atlanta (GA): American Cancer Society; 2005.
2. O Brien K, Cokkindies V, Jemal A, Cardinez CJ, Murray T, Samuels A, et al. Cancer statistics for Hispanics, 2003. CA Cancer J Clin 2003;53:208-26.
3. Ries LAG, Eisner MP, Kosary CL, editors. SEER cancer statistics review, 1975-2000, table VI-14 [Internet]. Bethesda (MD): National Cancer Institute; 2003 [cited 2004 Jul 20]. Available from: URL: http://seer.cancer.gov/csr/1975_2000.
4. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 2002;51:761-6.
5. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med 2002;35:199-206.
6. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21:132-7.
7. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
8. Zambrana RE, Breen N, Fox SA, Gutierrez-Mohamed ML. Use of cancer screening practices by Hispanic women: analyses by subgroup. Prev Med 1999;29:466-77.
9. Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, et al; American Cancer Society. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002;52:8-22.
10. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Alexandria (VA): International Medical Publishing; 1996. p. 89-103.
11. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
12. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-41.
13. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
14. Winawer SJ, Zauber AG, Ho MN, O Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New Engl J Med 1993;329:1977-81.
15. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
16. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New Engl J Med 2000;343:1603-7.
17. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
18. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
19. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. New Engl J Med 1993;328:1365-71.
20. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
21. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New Engl J Med 1992;326:653-7.
22. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged > or = 50 years-United States, 2001. MMWR Morb Mortal Wkly Rep 2003;52:193-6.
23. Guzman B. The Hispanic population: Census 2000 brief. Washington (DC): U.S. Census Bureau; 2001.
24. Thompson B, Coronado GD, Solomon CC, McClerran DF, Neuhouser ML, Feng Z. Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes Control 2002;13:719-28.
25. Winkleby MA, Snider J, Davis B, Jennings MG, Ahn DK. Cancer-related health behaviors and screening practices among Latinos: findings from a community and agricultural labor camp survey. Ethn Dis 2003;13:376-86.
26. Babey SH, Ponce NA, Etzioni DA, Spencer BA, Brown R. Cancer screening in California: racial and ethnic disparities persist. Los Angeles (CA): UCLA Center for Health Policy Research; 2003.
27. Mandelblatt JS, Gold K, O Malley AS, Taylor K, Cagney K, Hopkins JS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 1999;28:418-25.
28. Perez-Stable EJ, Sabogal F, Otero-Sabogal R. Use of cancer-screening tests in the San Francisco Bay area: comparison of Latinos and Anglos. J Natl Cancer Inst Monogr 1995;18:147-53.
29. Vernon SW, Briss PA, Tiro JA, Warnecke RB. Some methodologic lessons from cancer screening research. Cancer 2004;101(5 Suppl):1131-45.
30. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey questionnaire. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2002.
31. Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS. State-specific prevalence of selected chronic disease-related characteristics-Behavioral Risk Factor Surveillance System, 2001. MMWR Surveill Summ 2003;52:1-80.
32. Council of American Survey Research Organizations (CASRO). Report of the CASRO Completion Rates Task Force. New York: Audits and Surveys Company, Inc; 1982.
33. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2002 technical information and data [Internet]. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003 [cited 2004 Jul]. Available from: URL: http://www.cdc.gov/brfss/technical_infodata/surveydata/2002.htm.
34. American Cancer Society. Cancer prevention & early detection, Atlanta (GA): American Cancer Society; 2002. p. 26-33.
35. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082-91.
36. Coughlin SS, Uhler RJ, Richards T, Wilson KM. Breast and cervical cancer screening practices among Hispanic and non-Hispanic women residing near the United States-Mexico border, 1999-2000. Fam Community Health 2003;26:130-9.
37. Sheinfeld Gorin S, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med. Forthcoming.
38. Corbie-Smith G, Flagg, EW, Doyle JP, O Brien MA. Influence of usual source of care on differences by race/ethnicity in receipt of preventive services. J Gen Intern Med 2002;17:458-64.
39. Gordon NP, Rundall TG, Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care 1998;36:636-45.
40. Vitullo MW, Taylor AK. Latino adults' health insurance coverage: an examination of Mexican and Puerto Rican Subgroup Differences. J Health Care Poor Underserved 2002;13(4):504-25.
41. Tortolero-Luna G, Glober GA, Villarreal R, Palos G, Linares A. Screening practices and knowledge, attitudes, and beliefs about cancer among Hispanic and non-Hispanic white women 35 years old or older in Nueces County, Texas. J Natl Cancer Inst Monogr 1995;18:49-56.
42. Suarez L. Pap smear and mammogram screening in Mexican-American women: the effects of acculturation. Am J Public Health 1994;84:742-6.
43. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians colorectal cancer screening recommendations and practices. Prev Med 2003;36:352-62.
44. Mokdad AH, Stroup DF, Giles WH. Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep 2003;52:1-12.
45. National Telecommunication Information Administration. Falling through the net: defining the digital divide. Washington (DC): U.S. Department of Commerce; 2000. p. 13.
46. U.S. Census Bureau. 2001 supplementary survey summary, table P035. Age by language spoken at home by ability to speak English for the population 5 years and over. Washington (DC): American Community Survey Office; 2002.
47. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2000;9:229-32.
48. Mandelson MT, LaCroix AZ, Anderson LA, Nadel MR, Lee NC. Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization. Am J Epidemiol 1999;150:617-21.
49. Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev 2004;13(6):898-905.